BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang R, Zhang J, Li M, Yan P, Yin H, Zhai S, Zhu X, Hu P, Zhang J, Huang L, Li M, Sun Z, Meng T, Yang D, Huang Z. The Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Pan-Cancer. PPAR Res 2020;2020:6527564. [PMID: 33029111 DOI: 10.1155/2020/6527564] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu L, Feng J, Li J, Yu Q, Ji J, Wu J, Dai W, Guo C. The gut microbiome-bile acid axis in hepatocarcinogenesis. Biomed Pharmacother 2021;133:111036. [PMID: 33378947 DOI: 10.1016/j.biopha.2020.111036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Zhu K, Deng W, Deng H, Liu X, Wang G, Fu B. Identification of a Novel PPAR Signature for Predicting Prognosis, Immune Microenvironment, and Chemotherapy Response in Bladder Cancer. PPAR Res 2021;2021:7056506. [PMID: 35027921 DOI: 10.1155/2021/7056506] [Reference Citation Analysis]
3 Chen G, Yu M, Cao J, Zhao H, Dai Y, Cong Y, Qiao G. Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysis. Bioengineered 2021;12:5149-61. [PMID: 34384030 DOI: 10.1080/21655979.2021.1960775] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Wang X, Yao Z, Fang L. miR-22-3p/PGC1β Suppresses Breast Cancer Cell Tumorigenesis via PPARγ. PPAR Res 2021;2021:6661828. [PMID: 33777130 DOI: 10.1155/2021/6661828] [Reference Citation Analysis]
5 Feng G, Wang T, Xue F, Qi Y, Wang R, Yuan H. Identification of enhancer RNAs for the prognosis of head and neck squamous cell carcinoma. Head Neck 2021;43:3820-31. [PMID: 34569097 DOI: 10.1002/hed.26877] [Reference Citation Analysis]